GlassScriptPhysician profile
Justina George
NPI 1912512757
$3,815.22
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $839 · 2022: $2,956 · 2023: $20.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.35 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $370.84 | 2022 | |
| Impel Pharmaceuticals INC. | $255.61 | 2022 | |
| Sk Life Science, INC. | $255.20 | 2021-2022 | |
| Biogen, INC. | $248.49 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $228.05 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $191.11 | 2021-2022 | |
| Ucb, INC. | $177.11 | 2022 | |
| Amgen INC. | $153.09 | 2021-2022 | |
| Acorda Therapeutics, INC | $129.85 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $116.17 | 2021-2022 | |
| Genzyme Corporation | $104.45 | 2022 | |
| Tanabe Pharma America, INC. | $100.23 | 2021-2022 | |
| Lundbeck LLC | $82.06 | 2021-2022 | |
| Avion Pharmaceuticals | $79.62 | 2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $77.85 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $76.66 | 2022 | |
| Lilly USA, LLC | $74.99 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $70.69 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $63.48 | 2022 | |
| Kyowa Kirin, INC. | $61.81 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $56.55 | 2021 | |
| Banner Life Sciences, LLC | $54.06 | 2022 | |
| Amneal Pharmaceuticals LLC | $45.30 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $42.43 | 2022 | |
| Argenx US, INC. | $38.29 | 2022 | |
| Pfizer INC. | $36.05 | 2021 | |
| Grifols USA, LLC | $35.75 | 2022 | |
| Alexion Pharmaceuticals, INC. | $35.42 | 2021-2022 | |
| Genentech USA, INC. | $23.47 | 2022 | |
| Supernus Pharmaceuticals, INC. | $21.81 | 2022 | |
| Neurelis, INC. | $21.76 | 2021 | |
| Livanova USA, INC. | $19.00 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $19.00 | 2022 | |
| Aquestive Therapeutics, INC. | $18.55 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.86 | 2021 | |
| Ge Healthcare | $15.57 | 2022 | |
| Eisai INC. | $14.82 | 2022 | |
| Currax Pharmaceuticals LLC | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justina George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.